Oleacein. Translation from mediterranean diet to potential antiatherosclerotic drug

Current Pharmaceutical Design

Volumn 21, Issue 9, 2015, Pages 1205-1212

  Naruszewicz, Marek ^a   Czerwińska, Monika E ^a   Kiss, Anna K ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

3, 4 DHPEA EDA; Atherosclerosis; Mediterranean diet; Oleacein

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OLEACEIN; OLIVE OIL; PHENOL DERIVATIVE; UNCLASSIFIED DRUG; ALDEHYDE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; CARDIOVASCULAR RISK; CONJUGATION; DRUG BIOAVAILABILITY; DRUG STRUCTURE; ENDOTHELIAL PROGENITOR CELL; ENZYME INHIBITION; HEART PROTECTION; HUMAN; IN VITRO STUDY; MEDITERRANEAN DIET; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; BIOAVAILABILITY; DRUG EFFECTS;

ALDEHYDES; ANTIOXIDANTS; ATHEROSCLEROSIS; BIOLOGICAL AVAILABILITY; DIET, MEDITERRANEAN; ENDOTHELIAL PROGENITOR CELLS; HUMANS; NEUTROPHILS; PHENOLS;

EID: 84925840299     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666141007141137     Document Type: Article

References (66)

1. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. European Heart Journal 2008; 29: 1316-26.
2. Buckland G, Mayén AL, Agudo A, et al. population (EPIC-Spain). Am J Clin Nutrition 2012; 96: 142-9.
3. Knekt P, Ritz J, Pereira MA, et al. Antioxidant vitamins and coronary heart disease risk: A pooled analysis of 9 cohorts. Am J Clin Nutr 2004; 80: 1508-1520.
4. Bermudez B, Lopez S, Ortega A, Varela LM, Pacheco YM, Abia R, Muriana FJG. Oleic acid in olive oil: From a metabolic framework toward a clinical perspective. Curr Pharm Design 2011; 17: 831-43.
5. Hatanaka E, Levada-Pires AC, Pithon-Curi TC, Curi R. Systematic study on ROS production induced by oleic, linoleic, and -linolenic acids in human and rat neutrophils. Free Radical Bio Med 2006; 41: 1124-32.
6. Magdalon J, Vinolo MAR, Rodrigues HG, et al. Oral administration of oleic or linoleic acids modulates the production of inflammatory mediators by rat macrophages. Lipids 2012; 47: 803-12.
7. Fitó M, Cladellas M, De La Torre R, et al. Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: A randomized, crossover, controlled, clinical trial. Atherosclerosis 2005; 181: 149-58.
8. Fitó M, Covas MI, Lamuela-Raventós RM, Vila J, Torrents J, De La Torre C, Marrugat J. Protective effect of olive oil and its phenolic compounds against low density lipoprotein oxidation. Lipids 2000; 35: 633-8.
9. Soler-Rivas C, Espi_JC, Wichers HJ. Oleuropein and related compounds. J Sci Food Agr 2000; 80: 1013-23.
10. Paiva-Martins F, Pinto M. Isolation and characterization of a new hydroxytyrosol derivative from olive (Olea europaea) leaves. J of Agr Food Chem 2008; 56: 5582-8.
11. Selvaggini R, Servili M, Urbani S, Esposto S, Taticchi A, Montedoro G. Evaluation of phenolic compounds in virgin olive oil by direct injection in high-performance liquid chromatography with fluorometric detection. J Agr Food Chem 2006; 54: 2832-8.
12. Tovar M, Motilva MJ, Romero MP. Changes in the phenolic composition of virgin olive oil from young trees (Olea europaea L. cv. Arbequina) grown under linear irrigation strategies. J Agr Food Chem 2001; 49: 5502-5508.
13. Vierhuis E, Servili M, Baldioli M, Schols HA, Voragen AGJ, Montedoro G. Effect of enzyme treatment during mechanical extraction of olive oil on phenolic compounds and polysaccharides. J Agricultural Food Chem 2001; 49: 1218-23.
14. Kanakis P, Termentzi A, Michel T, Gikas E, Halabalaki M, Skaltsounis AL. From Olive Drupes to Olive Oil. An HPLCOrbitrap-based Qualitative and Quantitative Exploration of Olive Key Metabolites. Planta Med 2013.
15. Montedoro G, Servili M, Baldioli M, Selvaggini R, Miniati E, Macchioni A. Simple and hydrolyzable compounds in virgin olive oil. 3. Spectroscopic characterizations of the secoiridoid derivatives. J Agr Food Chem 1993; 41: 2228-34.
16. Hansen K, Adsersen A, Brøgger Christensen S, et al. Isolation of an angiotensin converting enzyme (ACE) inhibitor from Olea europaea and Olea lancea. Phytomedicine 1996; 2: 319-25.
17. Somanadhan B, Smitt UW, George V, et al. Angiotensin Converting Enzyme (ACE) inhibitors from Jasminum azoricum and Jasminum grandiflorum. Planta Med 1998; 64: 246-50.
18. Capozzi F, Piperno A, Uccella N. Oleuropein site selective hydrolysis by technomimetic nuclear magnetic resonance experiments. J Agr Food Chem 2000; 48: 1623-9.
19. Romero-Segura C, Garcia-Rodriguez R, Sanchez-Ortiz A, Sanz C, Perez A. G. The role of olive beta-glucosidase in shaping the phenolic profile of virgin olive oil. Food Res Int 2012; 45: 191-6.
20. Amiot M, Fleuriet A, Macheix JJ. Accumulation of oleuropein derivatives during olive maturation. Phytochemistry 1989; 28: 67-9.
21. Poerschmann J, Weiner B, Baskyr I. Organic compounds in olive mill wastewater and in solutions resulting from hydrothermal carbonization of the wastewater. Chemosphere 2013; 92: 1472-82.
22. Paiva-Martins F, Gordon MH. Isolation and characterization of the antioxidant component 3, 4-dihydroxyphenylethyl 4-formyl-3-formylmethyl-4-hexenoate from olive (Olea europaea) leaves. J Agric Food Chem 2001; 49: 4214-9.
23. Paiva-Martins F, Gordon MH. Interactions of ferric ions with olive oil phenolic compounds. J Agr Food Chem 2005; 53: 2704-9.
24. Vougogiannopoulou K, Lemus C, Halabalaki M, et al. One-step semisynthesis of oleacein and the determination as a 5-lipoxygenase inhibitor. J Nat Prod 2014; 77: 441-5.
25. Lipinski C, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev 1997; 23: 3-25.
26. Paiva-Martins F, Gordon MH, Gameiro P. Activity and location of olive oil phenolic antioxidants in liposomes. Chem Phys Lipids 2003; 124: 23-36.
27. Pinto J, Paiva-Martins F, Corona G, et al. Absorption and metabolism of olive oil secoiridoids in the small intestine. Brit J Nutr 2011; 105: 1607-18.
28. Bartholomé R, Haenen G, Hollman PCH, et al. Deconjugation kinetics of glucuronidated phase II flavonoid metabolites by_-glucuronidase from neutrophils. Drug Metab Pharmacok 2010; 25: 379-87.
29. Shimoi K, Saka N, Nozawa R, et al. Deglucuronidation of a flavonoid, luteolin monoglucuronide, during inflammation. Drug Metab Dispos 2001; 29: 1521-4.
30. Serra A, Rubió L, Borràs X, Macià A, Romero MP, Motilva MJ. Distribution of olive oil phenolic compounds in rat tissues after administration of a phenolic extract from olive cake. Mol Nutr Food Res 2012; 56: 486-96.
31. García-Villalba R, Carrasco-Pancorbo A, Nevedomskaya E, et al. Exploratory analysis of human urine by LC-ESI-TOF MS after high intake of olive oil: Understanding the metabolism of polyphenols. Anal Bioanal Chem 2010; 398: 463-75.
32. Janku I, Raskova H, Motl O, Blazek Z. Zur Blutdrucksenkenden Wirkung Der Olivenextrakte. Archives Internationales De Pharmacodynamie Et De Therapie 1957; 112: 342-7.
33. Kosak R, Stern P. Pharmakologie des blutdrucksenkenden Prinzips der Olivenblätter Planta Med 1959; 7: 118-21.
34. Fu S, Arráez-Roman D, Segura-Carretero A, et al. Qualitative screening of phenolic compounds in olive leaf extracts by hyphenated liquid chromatography and preliminary evaluation of cytotoxic activity against human breast cancer cells. Analytical Bioanalytical Chem 2010; 397: 643-54.
35. Fogliano V, Ritieni A, Monti SM, et al. Antioxidant activity of virgin olive oil phenolic compounds in a micellar system. J Sci Food Agr 1999; 79: 1803-8.
36. Malle E, Furtmüller PG, Sattler W, Obinger C. Myeloperoxidase: A target for new drug development? Brit J Pharmacol 2007; 152: 838-54.
37. Podrez E, Schmitt D, Hoff HF, Hazen SL. Myeloperoxidasegenerated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 1999; 103: 1547-60.
38. Visioli F, Bellomo G, Montedoro GF, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 1995; 117: 25-32.
39. Czerwi_ska M, Kiss AK, Naruszewicz M. A comparison of antioxidant activities of oleuropein and its dialdehydic derivative from olive oil, oleacein. Food Chem 2012; 131: 940-7.
40. Carlsson J, Edlund MBK, Hanstrom L. Bactericidal and cytotoxic effects of hypothiocyanite-hydrogen peroxide mixtures. Infect Immun 1984; 44: 581-6.
41. Pruitt K, Tenovuo J, Mansson-Rahemtulla B, Harrington P, Baldone DC. Is thiocyanate peroxidation at equilibrium in vivo? Biochim Biophys Acta 1986; 870: 385-91.
42. Chandler J, Day BJ. Thiocyanate: A potentially useful therapeutic agent with host defense and antioxidant properties. Biochem Pharmacol 2012; 84: 1381-7.
43. Flemmig J, Rusch D, Czerwi_ska ME, Rauwald HW, Arnhold J. Components of a standardised olive leaf dry extract (Ph. Eur.) promote hypothiocyanite production by lactoperoxidase. Arch Biochem Biophys 2014; 549: 17-25.
44. Angelino D, Gennari L, Blasa M, et al. Chemical and cellular antioxidant activity of phytochemicals purified from olive mill waste waters. J Agr Food Chem 2011; 59: 2011-8.
45. Werz O. Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin. Planta Med 2007; 73: 1331-57.
46. Bendini A, Cerretani L, Vecchi S, Carrasco-Pancorbo A, Lercker G. Protective effects of extra virgin olive oil phenolics on oxidative stability in the presence or absence of copper ions. J Agr Food Chem 2006; 54: 4880-7.
47. Paiva-Martins F, Santos V, Mangericão H, Gordon MH. Effects of copper on the antioxidant activity of olive polyphenols in bulk oil and oil-in-water emulsions. J Agr Food Chem 2006; 54: 3738-3743.
48. Paiva-Martins F, Fernandes J, Santos V, et al. Powerful protective role of 3, 4-dihydroxyphenylethanol-elenolic acid dialdehyde against erythrocyte oxidative-Lnduced hemolysis. J Agr Food Chem 2010; 58: 135-40.
49. Paiva-Martins F, Fernandes J, Rocha S, et al. Effects of olive oil polyphenols on erythrocyte oxidative damage. Mol Nutr Food Res 2009; 53: 609-16.
50. Fabiani R, De Bartolomeo A, Rosignoli P, et al. Virgin olive oil phenols inhibit proliferation of human promyelocytic leukemia cells (HL60) by inducing apoptosis and differentiation. J Nutr 2006; 136: 614-9.
51. Rosignoli P, Fuccelli R, Fabiani R, Servili M, Morozzi G. Effect of olive oil phenols on the production of inflammatory mediators in freshly isolated human monocytes. J Nutr Biochem 2013; 24: 1513-9.
52. Sindona G, Caruso A, Cozza A, et al. Anti-inflammatory effect of 3, 4-DHPEA-EDA [2-(3, 4-hydroxyphenyl) ethyl (3S, 4E)-4-formyl-3-(2-oxoethyl)hex-4-enoate] on primary human vascular endothelial cells. Curr Med Chem 2012; 19: 4006-13.
53. Medina E, De Castro A, Romero C, Brenes M. Comparison of the concentrations of phenolic compounds in olive oils and other plant oils: Correlation with antimicrobial activity. J Agr Food Chem 2006; 54: 4954-61.
54. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 2004; 61: 481-97.
55. Baetta R, Corsini A. Role of polymorphonuclear neutrophils in atherosclerosis: Current state and future perspectives. Atherosclerosis 2010; 210: 1-13.
56. Babior B. Phagocytes and oxidative stress. Am J Med 2000; 109: 33-44.
57. Czerwi_ska ME, Kiss AK, Naruszewicz M. Inhibition of human neutrophils NEP activity, CD11b/CD18 expression and elastase release by 3, 4-dihydroxyphenylethanol-elenolic acid dialdehyde, oleacein. Food Chem 2014; 153: 1-8.
58. Endtmann C, Ebrahimian T, Czech T, et al. Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: Implications for vascular regeneration. Hypertension 2011; 58: 394-403.
59. Imanishi T, Hano T, Nishio I. Angiotensin II accelarates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97-104.
60. Parzonko A, Czerwi_ska ME, Kiss AK, Naruszewicz M. Oleuropein and oleacein may restore biological functions of endothelial progenitor cells impaired by angiotensin II via activation of Nrf2/heme oxygenase-1 pathway. Phytomedicine 2013; 20: 1088-94.
61. Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 2013; 368: 1279-90.
62. Sluimer J, Kolodgie FD, Bijnens APJJ, et al. Thin-Walled Microvessels in Human Coronary Atherosclerotic Plaques Show Incomplete Endothelial Junctions. Relevance of Compromised Structural Integrity for Intraplaque Microvascular Leakage. J Am Coll Cardiol 2009; 53: 1517-27.
63. Leclercq A, Houard X, Philippe M, et al. Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment. J Leukocyte Biol 2007; 82: 1420-9.
64. Ylä-Herttuala S, Bentzon JF, Daemen M, et al. Stabilization of atherosclerotic plaques: An update. Eur Heart J 2013; 34: 3251-8.
65. Van Den Bouwhuijsen Q, Vernooij MW, Hofman A, Krestin GP, Van Der Lugt A, Witteman JCM. Determinants of magnetic resonance imaging detected carotid plaque components: The Rotterdam Study. Eur Heart J 2012; 33: 221-9.
66. Esposito L, Saam T, Heider P, et al. MRI plaque imaging reveals high-risk carotid plaques especially in diabetic patients irrespective of the degree of stenosis. BMC Medical Imaging 2010; 10.